Clinical Trials Browser

Phase 2 × edotecarin × Gastrointestinal × Clear all

NCT00087503 2008-04-01

Intravenous Edotecarin in Patients With Advanced Gastric Cancer That Has Progressed or Recurred After Chemotherapy

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms